CJC-1295 with DAC (Drug Affinity Complex) is a research-grade, long-acting Growth Hormone Releasing Hormone (GHRH) analog engineered for extended receptor activation. The DAC modification allows CJC-1295 to bind to albumin, significantly increasing its half-life and enabling prolonged stimulation of GHRH receptors in vitro. This extended activity profile makes it a valuable tool for studying sustained GH release, long-term somatotropic signaling, endocrine feedback regulation, and comparative GH response modeling.
Researchers commonly utilize CJC-1295 w/ DAC to explore chronic hypothalamic–pituitary axis behavior, extended GH pulse amplitude, receptor desensitization studies, and the effects of prolonged GHRH analog activity. Its predictable, long-duration profile offers a clear contrast to short-acting GHRH analogs, enabling detailed examination of time-dependent endocrine mechanisms under controlled laboratory conditions.
Research Use Only
This product is intended strictly for laboratory and in vitro research applications. CJC-1295 w/ DAC is NOT for human or veterinary use, diagnostic procedures, or therapeutic applications. Must be handled only by qualified professionals in a controlled research environment.
Product Care:
Store lyophilized CJC-1295 w/ DAC in a cool, dry environment protected from light and moisture.
After reconstitution, refrigerate at 2–8°C.
For extended long-term storage, freezing at –20°C is recommended to maintain peptide integrity.
Reviews
There are no reviews yet.